Alaunos Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Alaunos Therapeutics, Inc. (TCRT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum of 4.05% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum · last filed 2026-08-14
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2025-09-30 was 3.86%.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2023-06-30 was 3.51%, a 24.03% increase year-over-year.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2023-03-31 was 3.58%, a 119.63% increase year-over-year.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2022-09-30 was 2.94%, a 230.34% increase year-over-year.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2025 was 4.05%, a 9.46% increase from fiscal 2024.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2024 was 3.70%, a 5.41% increase from fiscal 2023.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2023 was 3.51%, a 115.34% increase from fiscal 2022.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2022 was 1.63%, a 226.00% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | 4.05% 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 3.86% 10-Q · filed 2025-11-14 | 4.05% 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | 4.05% 10-Q · filed 2026-08-14 | ||||
| 2024-12-31 | 3.70% 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | 3.70% 10-Q · filed 2025-11-14 | ||||
| 2023-12-31 | 3.51% 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | 3.51% 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | 3.51% 10-Q · filed 2023-08-14 | 3.51% 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | 3.58% 10-Q · filed 2024-05-15 | ||||
| 2022-12-31 | 1.63% 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | 2.94% 10-Q · filed 2023-11-14 | 1.63% 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | 2.83% 10-Q · filed 2023-08-14 | 1.63% 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | 1.63% 10-Q · filed 2023-05-10 | ||||
| 2021-12-31 | 0.50% 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | 0.89% 10-Q · filed 2022-11-14 | 0.50% 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | 0.09% 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | 0.09% 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | 0.36% 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | 0.36% 10-Q · filed 2021-11-08 | 0.36% 10-Q · filed 2021-11-08 | |||
| 2020-06-30 | 0.43% 10-Q · filed 2021-08-13 | 0.43% 10-Q · filed 2021-08-13 | |||
| 2020-03-31 | 0.36% 10-Q · filed 2021-05-06 | 0.50% 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | 1.39% 10-K · filed 2021-03-01 | ||||
| 2019-09-30 | 1.39% 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | 1.89% 10-Q · filed 2020-08-06 | ||||
| 2019-03-31 | 2.28% 10-Q · filed 2020-05-07 | ||||
| 2018-12-31 | 2.55% 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | 2.82% 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | 2.66% 10-Q · filed 2019-08-08 | ||||
| 2018-03-31 | 2.56% 10-Q · filed 2019-05-08 | ||||
| 2017-12-31 | 1.85% 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | 1.88% 10-Q · filed 2018-11-09 | ||||
| 2017-06-30 | 1.85% 10-Q · filed 2018-08-08 | ||||
| 2017-03-31 | 2.04% 10-Q · filed 2018-05-10 | ||||
| 2016-12-31 | 1.27% 10-K · filed 2019-03-05 | ||||
| 2016-09-30 | 1.27% 10-Q · filed 2017-11-06 | 1.27% 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | 1.38% 10-Q · filed 2017-07-31 | ||||
| 2016-03-31 | 1.58% 10-Q · filed 2017-05-01 | ||||
| 2015-12-31 | 1.46% 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | 1.66% 10-Q · filed 2016-11-09 | ||||
| 2015-03-31 | 1.63% 10-Q · filed 2016-05-10 | ||||
| 2014-12-31 | 1.74% 10-K · filed 2017-02-16 | ||||
| 2014-03-31 | 1.76% 10-Q · filed 2015-05-07 | ||||
| 2013-12-31 | 1.00% 10-K · filed 2016-02-24 | ||||
| 2013-09-30 | 1.61% 10-Q · filed 2014-10-30 | ||||
| 2013-03-31 | 1.00% 10-Q · filed 2014-05-08 | ||||
| 2012-12-31 | 0.79% 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | 0.79% 10-Q · filed 2013-10-22 | ||||
| 2012-06-30 | 0.93% 10-Q · filed 2013-08-08 | ||||
| 2012-03-31 | 1.11% 10-Q · filed 2013-05-07 | ||||
| 2011-12-31 | 1.09% 10-K · filed 2014-03-03 | ||||
| 2011-09-30 | 1.12% 10-Q · filed 2012-11-08 | ||||
| 2011-06-30 | 1.83% 10-Q/A · filed 2012-08-28 | ||||
| 2010-12-31 | 1.13% 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |